학술논문
Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody
Document Type
Article
Author
Source
In European Journal of Medicinal Chemistry 5 March 2024 267
Subject
Language
ISSN
0223-5234